Saw Palmetto
On sale on the US market (according to the DSLD)
Herb Pharm, food supplement from the US market
Saw Palmetto (Herb Pharm), a food supplement au code-barres 090800000218, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Herb Pharm
- Barcode
- 090800000218
- Form
- Liquid
- One serving
- 0.7 ml
- Servings
- up to 3 servings per day
- Other ingredients (in English, as written)
- Cane Alcohol, Water, Distilled
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Saw Palmetto Berry Extract (Serenoa repens) | Plant | 598 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Saw Palmetto
Entered into DSLD on 22 May 2020. Withdrawn from the US market on 27 November 2023 (according to the DSLD).- Same quantity, different name: Saw Palmetto berry (Serenoa repens) extract in this version; Saw Palmetto Berry Extract on the displayed label (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 24 July 2019. Withdrawn from the US market on 27 January 2020 (according to the DSLD).- Same quantity, different name: Saw Palmetto berry (Serenoa repens) extract in this version; Saw Palmetto Berry Extract on the displayed label (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 25 February 2019. Withdrawn from the US market on 14 February 2019 (according to the DSLD).- Same quantity, different name: Saw Palmetto berry (Serenoa repens) extract in this version; Saw Palmetto Berry Extract on the displayed label (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 21 September 2017. Withdrawn from the US market on 8 August 2018 (according to the DSLD).- Same quantity, different name: Saw Palmetto berry (Serenoa repens) extract in this version; Saw Palmetto Berry Extract on the displayed label (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 25 July 2016. Withdrawn from the US market on 17 March 2017 (according to the DSLD).- Same quantity, different name: Saw Palmetto berry (Serenoa repens) extract in this version; Saw Palmetto Berry Extract on the displayed label (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 25 February 2015. Withdrawn from the US market on 1 June 2016 (according to the DSLD).- Same quantity, different name: Saw Palmetto berry (Serenoa repens) extract in this version; Saw Palmetto Berry Extract on the displayed label (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 25 November 2014. Withdrawn from the US market on 17 February 2015 (according to the DSLD).- Active ingredient added : provides 320 mg Fatty Acids (320 mg)
- Active ingredient added : Saw Palmetto liquid extract (quantity not stated)
- Active ingredient removed : Saw Palmetto Berry Extract (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 25 April 2014. Withdrawn from the US market on 3 November 2014 (according to the DSLD).- Active ingredient added : provides 320 mg Fatty Acids (320 mg)
- Active ingredient added : Saw Palmetto liquid extract (quantity not stated)
- Active ingredient removed : Saw Palmetto Berry Extract (598 mg)
Official label: Saw Palmetto
Entered into DSLD on 23 August 2013. Withdrawn from the US market on 14 April 2014 (according to the DSLD).- Active ingredient added : Saw Palmetto Liquid Extract (quantity not stated)
- Active ingredient removed : Saw Palmetto Berry Extract (598 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Saw Palmetto Berry Extract
Read the warning, when it applies and the studies cited
SAW PALMETTO – SERENOA REPENS
Route of administration: Oral
Cautions and warnings
Condition of application: All subpopulations.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Adult males only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to exclude a diagnosis of prostate cancer (USP-NF 2024; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
- USP-NF 2024: United States Pharmacopeia and the National Formulary. Rockville (MD): The United States Pharmacopeial Convention, Inc.; 2024.
Condition of application: Adult females only.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking oral contraceptives or hormone replacement therapy (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
Contraindications
Condition of application: Adult females only.
Do not use if you are pregnant, breastfeeding, or attempting to conceive (UpToDate 2024).
Sources cited by Health Canada (1)
- UpToDate 2024. UpToDate database. Clinical use of Saw palmetto. [Consulted 2024 December 5]. Available from : https://www.uptodate.com/contents/clinical-use-of-saw-palmetto?search=saw%20palmetto&source=search_result&selectedTitle=1%7E9&usage_type=default&display_rank=1
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Herb Pharm
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Saw Palmetto (Herb Pharm): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/90800000218-saw-palmetto-herb-pharm, updated 22 March 2024.